NCT02081729View on ClinicalTrials.gov

Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)

TerminatedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Kidney Transplantation
Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Korea Advanced Institute of Science and Technology

OTHER

lead

Asan Medical Center

OTHER

NCT02081729 - Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT) | Biotech Hunter | Biotech Hunter